Award
National Institute of Allergy and Infectious Diseases (NIAID) 75N93022D00003-0-759302300001-1
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanoparticle Based HIV Immunogens
Recipient
Duke University
Award Amount
$6,174,301.00
Ceiling
$6,174,301.00
Awarded
August 30, 2023
Identifier
75N93022D00003-0-759302300001-1
Award for cGMP manufacture and testing of mRNA lipid nanoparticle HIV immunogens to support vaccine development, with a funding amount of approximately $6.17 million from NIAID/NIH.
Description
The project supports preclinical and translational vaccine development for HIV and other agents, providing capabilities for process and product development, small-scale production, preclinical testing, and documentation leading to IND submissions.